Preferences help
enabled [disable] Abstract
Number of results
2003 | 50 | 4 | 1119-1128
Article title

Inhibition of collagen-induced platelet reactivity by DGEA peptide.

Title variants
Languages of publication
Direct interactions between collagen, the most thrombogenic component of the extracellular matrix, and platelet surface membrane receptors mediate platelet adhesion and induce platelet activation and aggregation. In this process two glycoproteins are crucial: integrin α2β1, an adhesive receptor, and GPVI, which is especially responsible for signal transduction. Specific antagonists of the collagen receptors are useful tools for investigating the complexity of platelet-collagen interactions. In this work we assessed the usefulness of DGEA peptide (Asp-Gly-Glu-Ala), the shortest collagen type I-derived motif recognised by the collagen-binding integrin α2β1, as a potential antagonist of collagen receptors. We examined platelet function using several methods including platelet adhesion under static conditions, platelet function analyser PFA-100TM, whole blood electric impedance aggregometry (WBEA) and flow cytometry. We found that DGEA significantly inhibited adhesion, aggregation and release reaction of collagen activated blood platelets. The inhibitory effect of DGEA on static platelet adhesion reached sub-maximal values at millimolar inhibitor concentrations, whereas the specific blocker of α2β1 - monoclonal antibodies Gi9, when used at saturating concentrations, had only a moderate inhibitory effect on platelet adhesion. Considering that 25-30% of total collagen binding to α2β1 is specific, we conclude that DGEA is a strong antagonist interfering with a variety of collagen-platelet interactions, and it can be recognised not only by the primary platelet adhesion receptor α2β1 but also by other collagen receptors.
Physical description
  • Department of Haemostasis and Haemostatic Disorders, Medical University of Łódź, Łódź, Poland
  • Department of Haemostasis and Haemostatic Disorders, Medical University of Łódź, Łódź, Poland
  • Department of Haemostasis and Haemostatic Disorders, Medical University of Łódź, Łódź, Poland
  • Department of Haemostasis and Haemostatic Disorders, Medical University of Łódź, Łódź, Poland
  • Department of Haemostasis and Haemostatic Disorders, Medical University of Łódź, Łódź, Poland
  • Barnes MJ, Knight CG, Farndale RW. (1996) The use of collagen-based model peptides to investigate platelet-reactive sequences in collagen. Biopolymers.; 40: 383-97.
  • Bartlett A, Dormandy KM, Hawkey CM, Stableforth P, Voller A. (1976) Factor-VIII-related antigen: measurement by enzyme immunoassay. Br Med J.; 1: 994-6.
  • Bellavite P, Andrioli G, Guzzo P, Arigliano P, Chirumblo S, Manzato F, Santonastaso C. (1994) A colorimetric method for the measurement of platelet adhesion in microtiter plates. Anal Biochem.; 216: 444-50.
  • Bock M, De Haan J, Beck KH, Gutensohn K, Hertfelder HJ, Karger R, Heim MU, Beeser H, Weber D, Kretschmer V. (1999) Standardization of the PFA-100(R) platelet function test in 105 mmol/l buffered citrate: effect of gender, smoking, and oral contraceptives. Br J Haematol.; 106: 898-904.
  • Clemetson KJ. (1999) Platelet collagen receptors: a new target for inhibition? Haemostasis.; 29: 16-26.
  • Coller BS, Beer JH, Scudder LE, Steinberg MH. (1989) Collagen-platelet interactions: evidence for a direct interaction of collagen with platelet GPIa/IIa and an indirect interaction with platelet GPIIb/IIIa mediated by adhesive proteins. Blood.; 74: 182-92.
  • De Luca M, Ward CM, Ohmori K, Andrews RK, Berndt MC. (1995) Jararhagin and jaracetin: novel snake venom inhibitors of the integrin collagen receptor, α2β1. Biochem Biophys Res Commun.; 206: 570-6.
  • Di Paola J, Federici AB, Mannucci PM, Canciani MT, Kritzik M, Kunicki TJ, Nugent D. (1999) Low platelet α2β1 levels in type I von Willebrand disease correlate with impaired platelet function in a high shear stress system. Blood.; 93: 3578-82.
  • Favaloro EJ. (2001) Utility of the PFA-100 for assessing bleeding disorders and monitoring therapy: a review of analytical variables, benefits and limitations. Haemophilia.; 7: 170-79.
  • Favaloro EJ. (2002) Clinical application of the PFA-100(R). Curr Opin Hematol.; 9: 407-15.
  • Inoue K, Ozaki Y, Satoh K, Wu Y, Yatomi Y, Shin Y, Morita T. (1999) Signal transduction pathways mediated by glycoprotein Ia/IIa in human platelets: comparison with those of glycoprotein VI. Biochem Biophys Res Commun.; 256: 114-20.
  • Inoue O, Suzuki-Inoue K, Dean WL, Frampton J, Watson SP. (2003) Integrin α2β1 mediates outside-in regulation of platelet spreading on collagen through activation of Src kinases and PLCγ2. J Cell Biol.; 160: 769-80.
  • Jarvis GE, Atkinson BT, Snell DC, Watson SP. (2002) Distinct roles of GPVI and integrin α2β1 in platelet shape change and aggregation induced by different collagens. Br J Pharmacol.; 137: 107-17.
  • Jung SM, Moroi M. (1998) Platelets interact with soluble and insoluble collagens through characteristically different reactions. J Biol Chem.; 273: 14827-37.
  • Jung SM, Moroi M. (2000) Signal-transducing mechanisms involved in activation of the platelet collagen receptor integrin α2β1. J Biol Chem.; 275: 8016-26.
  • Kamiguti AS, Hay CR, Zuzel M. (1996) Inhibition of collagen-induced platelet aggregation as the result of cleavage of α2β1-integrin by the snake venom metalloproteinase jararhagin. Biochem J.; 320: 635-41.
  • Kamiguti AS, Markland FS, Zhou Q, Laing GD, Theakston RD, Zuzel M. (1997) Proteolytic cleavage of the β1 subunit of platelet α2β1 integrin by the metalloproteinase jararhagin compromises collagen-stimulated phosphorylation of pp72. J Biol Chem.; 272: 32599-605.
  • Knight CG, Morton LF, Onley DJ, Peachey AR, Messent AJ, Smethurst PA, Tukwell DS, Farndale RW, Barnes MJ. (1998) Identification in collagen type I of an integrin α2 β1-binding site containing an essential GER sequence. J Biol Chem.; 273: 33287-94.
  • Knight CG, Morton LF, Peachey AR, Tuckwell DS, Farndale RW, Barnes MJ. (2000) The collagen-binding A-domains of integrins α1β1 and α2β1 recognize the same specific amino acid sequence, GFOGER, in native (triple-helical) collagens. J Biol Chem.; 275: 35-40.
  • Kundu SK, Heilmann EJ, Sio R, Garcia C, Davidson RM, Ostgaard RA. (1995) Description of an in vitro platelet function analyzer-PFA-100. Semin Thromb Hemost.; 21 (Suppl 2): 106-12.
  • Liu CZ, Wu TF, Huang TF, Wu DH, Lin GL. (2002) Trimucytin, a collagen-like snake venom protein, activates platelets independent of I-domain within α2 subunit of α2β1 integrin. Thromb Res.; 105: 153-60.
  • McCann TJ, Terranova G, Keyte JW, Papaioannou SS, Mason WT, Meikle MC, McDonald F. (1998) An analysis of Ca2+ release by DGEA: mobilization of two functionally distinct internal stores in Saos-2 cells. Am J Physiol.; 275: C33-41.
  • Mizuno M, Fujisawa R, Kuboki Y. (2000) Type I collagen-induced osteoblastic differentiation of bone-marrow cells mediated by collagen-α2β1 integrin interaction. J Cell Physiol.; 184: 207-13.
  • Monnet E, Sizaret P, Arbeille B, Fauvel-Lafeve F. (2000) Different role of platelet glycoprotein GP Ia/IIa in platelet contact and activation induced by type I and type III collagens. Thromb Res.; 98: 423-33.
  • Moroi M, Jung SM, Shinmyozu K, Tomiyama Y, Ordinas A, Diaz-Ricart M. (1996) Analysis of platelet adhesion to a collagen-coated surface under flow conditions: the involvement of glycoprotein VI in the platelet adhesion. Blood.; 88: 2081-92.
  • Moroi M, Jung SM, Nomura S, Sekiguchi S, Ordinas A, Diaz-Ricart M. (1997) Analysis of the involvement of the von Willebrand factor-glycoprotein Ib interaction in platelet adhesion to a collagen-coated surface under flow conditions. Blood.; 90: 4413-24.
  • Moroi M, Onitsuka I, Imaizumi T, Jung SM. (2000) Involvement of activated integrin α2β1 in the firm adhesion of platelets onto a surface of immobilized collagen under flow conditions. Thromb Haemost.; 83: 769-76.
  • Nakamura T, Jamieson GA, Okuma M, Kambayashi J, Tandon NN. (1998) Platelet adhesion to native type I collagen fibrils. Role of GPVI in divalent cation-dependent and -independent adhesion and thromboxane A2 generation. J Biol Chem.; 273: 4338-44.
  • Nakamura T, Kambayashi J, Okuma M, Tandon NN. (1999) Activation of the GP IIb-IIIa complex induced by platelet adhesion to collagen is mediated by both α2β1 integrin and GP VI. J Biol Chem.; 274: 11897-903.
  • Perret S, Eble JA, Siljander PR, Merle C, Farndale RW, Theisen M, Ruggiero F. (2003) Prolyl hydroxylation of collagen type I is required for efficient binding to integrin α1β1 and platelet glycoprotein VI but not to α2β1. J Biol Chem.; 278: 29873-9.
  • Ray MJ, Hawson GA, Just SJ, Mc Lachlan G, O'Brien M. (1994) Relationship of platelet aggregation to bleeding after cardiopulmonary bypass. Ann Thorac Surg.; 57: 981-6.
  • Rozalski M, Boncler M, Golanski J, Watala C. (2001) Effects of fibrinogen receptor antagonist GR144053F and aurintricarboxylic acid on platelet activation and degranulation. Biochem Pharmacol.; 62: 1399-408.
  • Salat A, Kroess S, Felfernig-Boehm D, Felfernig M, Fleck T, Schmidt D, Pulaki S, Mueller MR. (2002) Comparison of in vitro closure time (PFA-100) with whole blood electrical aggregometry and platelet surface antigen expression in healthy volunteers. Thromb Res.; 105: 205-8.
  • Siljander P, Lassila R. (1999) Studies of adhesion-dependent platelet activation: distinct roles for different participating receptors can be dissociated by proteolysis of collagen. Arterioscler Thromb Vasc Biol.; 19: 3033-43.
  • Sixma JJ, van Zanten GH, Huizinga EG, van der Plas RM, Verkley M, Wu YP, Gros P, de Groot PG. (1997) Platelet adhesion to collagen: an update. Thromb Haemost.; 78: 434-8.
  • Staatz WD, Fok KF, Zutter MM, Adams SP, Rodriguez BA, Santoro SA. (1991) Identification of a tetrapeptide recognition sequence for the α2β1 integrin in collagen. J Biol Chem.; 266: 7363-7.
  • Suzuki-Inoue K, Ozaki Y, Kainoh M, Shin Y, Wu Y, Yatomi Y, Ohmori T, Tanaka T, Satoh K, Morita T. (2001) Rhodocytin induces platelet aggregation by interacting with glycoprotein Ia/IIa (GPIa/IIa, integrin α2β1). Involvement of GPIa/IIa-associated src and protein tyrosine phosphorylation. J Biol Chem.; 276: 1643-52.
  • Watson SP. (1999) Collagen receptor signalling in platelets and megakaryocytes. Thromb Haemost.; 82: 365-76.
  • Watson S, Berlanga O, Best D, Frampton J. (2000) Update on collagen receptor interactions in platelets: is the two-state model still valid? Platelets.; 11: 252-8.
  • Wu YP, Vink T, Schiphorst M, van Zanten GH, IJsseldijk MJ, de-Groot PG, Sixma JJ. (2000) Platelet thrombus formation on collagen at high shear rates is mediated by von Willebrand factor-glycoprotein Ib interaction and inhibited by von Willebrand factor-glycoprotein IIb/IIIa interaction. Arterioscler Thromb Vasc Biol.; 20: 1661-7.
  • Yamamoto M, Yamato M, Aoyagi M, Yamamoto K. (1995) Identification of integrins involved in cell adhesion to native and denatured type I collagens and the phenotypic transition of rabbit arterial smooth muscle cells. Exp Cell Res.; 219: 249-56.
Document Type
Publication order reference
YADDA identifier
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.